Borrower record · Q2 2026
HemaSource
As filed by 4 BDCs · period end 30 June 2026Filers label it: Healthcare & Pharmaceuticals (4)1 name variant under review
Four lenders report $25.1m of HemaSource at Q2 2026, marked at 102.4 cents. The filed maturities run to February 2030.
- Filed fair value
- $25.1m
- 10 funded positions
- Reporting lenders
- 4
- across 10 filed positions
- Aggregate mark
- 102.4c
- cost filed on all 10 positions
- Median spread
- 450bp
- over SOFR, 6 tranches
- Maturities to
- 2030
- earliest August 2029
- Periods on record
- 5
- Q2 2025 → Q2 2026
How this total is counted
- Every figure above is the sum of 10 funded positions filed by 4 BDCs, each one cited below.
- Counted from the Q2 2026 filings imported for this build, the latest of them filed 20 August 2026. A schedule filed after that date is not in these figures and will appear when the property is rebuilt.
- 1 filed name variant is under review against this borrower. Until it is resolved, anything filed under that name is counted nowhere on this page.
Pricing as filed
6 floating tranches · SOFR450bp on all 6 floating tranches — every filer reports the same spread.
Capital structure
Bars show position counts. All 10 funded positions carry a filed seniority.
Rate structure
Bars show position counts. 6 of 7 classified positions are floating. 3 positions carry no filed interest type.
Maturity profile
7 of 10 funded positions dated · counts only3.2 years to maturity, weighted by fair value across the 7 dated positions.
Where the lenders disagree
4 filers disclosed a costLender marks on the same debt differ by up to 3.0c.
Filed over time
5 periods · aggregate onlyFiled fair value
Aggregate marknot to zero
Q2 2025, Q3 2025, Q4 2025, Q1 2026, Q2 2026 — every filer reporting the borrower at each period, aggregated. No lender is separated out at any period.
Credit flags
No lender reports this borrower on non-accrual, and no filed tranche pays in kind.
Not in the filings
- No sector. 4 filers file the same industry string, shown above as filed, but it has not cleared the corroboration test.
- No values on the breakdowns — position counts only. With 4 lenders reporting, splitting the total along those dimensions would give up a per-lender figure that sits behind the gate.
- No maturity on 3 of 10 funded positions. Undated is left undated, not assumed.
- No index floor filed on any tranche.
Sign up for free
Who holds it, and where they mark it.
4 lenders hold the same credit and mark it differently. Behind the gate, one row each — for this borrower and for every other one on this site, free and with no limit on how many you read.
- The spread between the highest and lowest lender mark
- Quarter-on-quarter movement across 5 periods
- Peer comparison against borrowers with the same lenders
- The 10-Q or 10-K behind every row, by accession number
Every filing behind this page
4 filers · Q2 2026| Filer | CIK | Form | Period | Filed | Accession |
|---|---|---|---|---|---|
| Barings BDC, Inc. (BBDC) | 0001379785 | 10-Q | 2026-06-30 | 2026-08-05 | 0001379785-26-000030 |
| Barings Capital Investment Corp | 0001811972 | 10-Q | 2026-06-30 | 2026-08-05 | 0001811972-26-000018 |
| Barings Private Credit Corp | 0001859919 | 10-Q | 2026-06-30 | 2026-08-05 | 0001859919-26-000068 |
| Nuveen Churchill Direct Lending Corp. (NCDL) | 0001737924 | 10-Q | 2026-06-30 | 2026-08-06 | 0001737924-26-000084 |
Related borrowers
Same lenders